16-30 of 37
The Latest Patient-Centered Recommendations From the 7th World Symposium on PH
MinuteCE®The Latest Patient-Centered Recommendations From the 7th World Symposium on PH
A Comparison of PROMs and How to Use Them in Clinical Practice for PAH
MinuteCE®A Comparison of PROMs and How to Use Them in Clinical Practice for PAH
Aligning PAH Treatment Plans With Key Care Goals and Your Patients’ Priorities
MinuteCE®Aligning PAH Treatment Plans With Key Care Goals and Your Patients’ Priorities
PROMs: Role in Clinical Research and Contributions to PAH Patient Perspectives
MinuteCE®PROMs: Role in Clinical Research and Contributions to PAH Patient Perspectives
New and Emerging PAH Therapies and Approaches: A Mixture of Hope and Complexity
CME/CE Broadcast ReplayNew and Emerging PAH Therapies and Approaches: A Mixture of Hope and Complexity
PH Management in Unique Patients and Conditions
CME/CE Broadcast ReplayPH Management in Unique Patients and Conditions
- advertisement
The Safety of Sodium Oxybate in Treating Narcolepsy
CME/CEThe Safety of Sodium Oxybate in Treating Narcolepsy
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
CME/CEPatient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Pulmonary Hypertension Management: Practice Trends and Updates
CME/CE Broadcast ReplayPulmonary Hypertension Management: Practice Trends and Updates
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
CME/CE Broadcast ReplayRisk Assessment in Pulmonary Hypertension: Practice Trends and Updates
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
CME/CE Broadcast ReplayPulmonary Hypertension: Comorbidities With PAH and Group 2 PH
Updates From the 7th World Symposium Task Force
CME/CEUpdates From the 7th World Symposium Task Force
- advertisement
Advances in Minimally Invasive Screening for Lung Cancer
CME/CEAdvances in Minimally Invasive Screening for Lung Cancer
Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
CME/CEExpert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC























































































